Basic research on dopamine in Parkinson's disease and the discovery of the nigrostriatal dopamine pathway: The view of an eyewitness

Neurodegenerative Diseases

Volumn 5, Issue 3-4, 2008, Pages 114-117

  Hornykiewicz, Oleh ^a,b  

^a Medical University of Vienna   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Dopamine; Nigrostriatal dopamine pathway; Parkinson's disease; Striatum

Indexed keywords

DOPAMINE; LEVODOPA;

ACHIEVEMENT; BASIC RESEARCH; CAREER; CLINICAL RESEARCH; CONFERENCE PAPER; HISTORY OF MEDICINE; HUMAN; JOB PERFORMANCE; MEDICAL RESEARCH; NIGRONEOSTRIATAL SYSTEM; OBSERVATION; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

ANIMALS; ANTIPARKINSON AGENTS; CORPUS STRIATUM; DOPAMINE; HISTORY, 20TH CENTURY; HUMANS; LEVODOPA; NEURAL PATHWAYS; PARKINSON DISEASE; SUBSTANTIA NIGRA;

EID: 40449124460     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000113678     Document Type: Conference Paper

References (24)

1. Weber G: Zum Cholinesterasegehalt des Gehirns bei Hirntumoren und bei Parkinsonismus. Bull Schweiz Akad Med Wiss 1952;8:263-268.
2. Bertler A, Rosengren E: Occurrence and distribution of dopamine in brain and other tissues. Experientia 1959;15:10-11.
3. Sano T, Gamo T, Kakimoto Y, Taniguchi K, Takesada M, Nishinuma K: Distribution of catechol compounds in human brain. Biochim Biophys Acta 1959;32:586-587.
4. Montagu XA: Catechol compounds in rat tissues and in brains of different animals. Nature 1957;180:244-245.
5. Holtz P, Balzer H, Westermann E, Wezler R: Beeinflussung der Evipannarkose durch Reserpin, Iproniazid and biogene Amine. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol 1957;231:333-348.
6. Weil-Malherbe H, Bone AD: Intracellular distribution of catecholamine in the brain. Nature 1957;180:1050-1051.
7. Carlsson A, Lindqvist M, Magnusson T: 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature 1957;180:1200.
8. Pletscher A: Wirkung von Isopropyl-Isonikotinsäurehydrazid auf den Stoffwechsel von Catecholaminen und 5-Hydroxytryptamin im Gehirn. Schweiz Med Wochenschr 1957;87:1532-1534.
9. Carlsson A, Lindqvist M, Magnusson T, Waldeck B: On the presence of 3-hydroxytyramine in brain. Science 1958;127:471.
10. Weil-Malherbe H, Bone AD: Effect of reserpine on the intracellular distribution of catecholamines in the brainstem of the rabbit. Nature 1958;181:1474-1475.
11. Holzer G, Hornykiewicz O: Über den Dopamin-(Hydroxytyramin-) Stoffwechsel im Gehirn der Ratte. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol 1959;137:27-33.
12. Ehringer H, Hornykiewicz O: Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Klin Wochenschr 1960;38:1236-1239.
13. Hornykiewicz O: Dopamine miracle: from brain homogenate to dopamine replacement. Mov Disord 2002;17:502-508.
14. Birkmayer W, Hornykiewicz O: Der L-dioxyphenylalanin ( L -dopa)-Effekt bei der Parkinson-Akinese. Wien Klin Wochenschr 1961;73:787-788.
15. Barbeau A, Sourkes TL, Murphy GF: Les catecholamines dans la maladie de Parkinson; in de Ajuríaguerra J (ed): Monoamines et système nerveux-centrale. Geneva, Georg, 1962, pp 247-262.
16. Cotzias CC, Van Woert MH, Schiffer IM: Aromatic amino acids and modification of parkinsonism. N Engl J Med 1967;276:374-379.
17. Hassler R: Zur Pathologie der Paralysis agitans und des postenzephalitischen Parkinsonismus. J Psychol Neurol 1938;48:387-476.
18. Hassler R, Jung R: The extrapyramidal motor system;in Field J, Magoun HW, Hall VE (eds): Handbook of Physiology. Section 1: Neurophysiology, vol 2. Washington, American Physiological Society, 1960, pp 863-927.
19. Mettler FA: Substantia nigra parkinsonism. Arch Neurol 1964;11:529-542.
20. Hornykiewicz O: Die topische Lokalisation und das Verhalten von Noradrenalin und Dopamin (3-Hydroxytyramin) in der Substantia nigra des normalen und Parkinsonkranken Menschen. Wien Klin Wochenschr 1963;75:309-312.
21. Foirier LJ, Sourkes TL: Influence de locus niger sur la concentration des catecholamines du striatum. J Physiol (Paris) 1964;56:426-427.
22. Dahlström A, Fuxe K: Evidence for the existence of monoamine-containing neurons in the central nervous system. 1. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol Scand 1964;62(suppl 232):1-55.
23. Carpenter M: Discussion; in Costa E, Cotê LJ, Yahr MD (eds): Biochemistry and Pharmacology of the Basal Ganglia. Hewlett, Raven Press, 1966, p 191.
24. Moore RY: The nigrostriatal pathway: demonstration by anterograde degeneration;in Barbeau A, McDowell FH (eds): L-Dopa and Parkinsonism. Philadelphia, FA Davies Company, 1970, pp 143-149.